We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Nastech's Generic Osteoporosis Treatment Not Approvable
Nastech's Generic Osteoporosis Treatment Not Approvable
July 25, 2006
Nastech Pharmaceuticals has received a “not approvable” letter from the FDA for its abbreviated new drug application (ANDA) for a generic nasal treatment for osteoporosis, the company said June 13.